Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

GLOBAL: Briton Fights for Self-Destruct Syringes in Tanzania




 

The Guardian (London) (10.29.11) - Wednesday, November 02,

A British entrepreneur and designer of an auto-disable (AD) syringe is on a mission to get such devices widely adopted to prevent syringe re-use, which can transmit infectious diseases such as HIV and hepatitis B and C. Tanzania is one of the countries using the AD syringes, said Marc Koska, founder of SafePoint, a charity that advocates for the use of any quality-assured brand of AD syringe.

A 2000 World Health Organization study estimated 23 million hepatitis B and C transmissions were attributable to unsafe injection practices each year, costing $119 billion in annual medical costs and lost productivity. Koska hopes to persuade four other east African countries to use AD syringes before taking on the global market.

The largest procurer of routine childhood immunizations, UNICEF, provides safe syringes along with the vaccines, Koska noted. But that leaves out "the other 90 percent" of injections, he said.

At 0.03 GBP (US $0.05) apiece, syringes are cheap to manufacture. A small number of large companies make them, bundling them as a loss leader with other higher-margin products. AD syringes can be made cheaply made after initially expensive changes in the production process.

With Koska's AD syringe, the plunger breaks upon attempted re- use. Three billion have been sold.



 


Copyright © 2011 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in November 2, 2011. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.